Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors
- PMID: 27581632
- DOI: 10.1248/cpb.c16-00221
Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors
Abstract
A series of pyridinium salts bearing alkylphenyl groups at 1 position and hydrazone structure at 4 position of the pyridinium ring were synthesized and evaluated for the inhibition of both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes. The cholinesterase (ChE) inhibitory activity studies were carried out by using the Ellman's colorimetric method. All compounds displayed considerable AChE and BuChE inhibitory activity and some of the compounds manifested remarkable anti-AChE activity compared to the reference compound, galantamine. Among the title compounds, the series including benzofuran aromatic ring exhibited the best inhibitory activity both on AChE and BuChE enzymes. Compound 3b, 4-[2-(1-(benzofuran-2-yl)ethylidene)hydrazinyl]-1-(3-phenylpropyl)pyridinium bromide, was the most active compound with IC50 value of 0.23 (0.24) µM against enantiomeric excess (ee)AChE (human (h)AChE) while compound 3a, 4-[2-(1-(benzofuran-2-yl)ethylidene)hydrazinyl]-1-phenethylpyridinium bromide, was the most active compound with IC50 value of 0.95 µM against BuChE. Moreover, 3a and b exhibited higher activity than the reference compound galantamine (eeAChE (hAChE) IC50 0.43 (0.52) µM; BuChE IC50 14.92 µM). Molecular docking studies were carried out on 3b having highest inhibitory activity against AChE.
Similar articles
-
Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.Bioorg Chem. 2018 Apr;77:311-319. doi: 10.1016/j.bioorg.2018.01.013. Epub 2018 Jan 31. Bioorg Chem. 2018. PMID: 29421707
-
Synthesis, biological evaluation, and docking studies of some 5-chloro-2(3H)-benzoxazolone Mannich bases derivatives as cholinesterase inhibitors.Arch Pharm (Weinheim). 2018 Apr;351(3-4):e1700273. doi: 10.1002/ardp.201700273. Epub 2018 Mar 12. Arch Pharm (Weinheim). 2018. PMID: 29527733
-
Novel Iodinated Hydrazide-hydrazones and their Analogues as Acetyl- and Butyrylcholinesterase Inhibitors.Curr Top Med Chem. 2020;20(23):2106-2117. doi: 10.2174/1568026620666200819155503. Curr Top Med Chem. 2020. PMID: 32814531
-
Recent developments in the synthesis of acetylcholinesterase inhibitors.Mini Rev Med Chem. 2003 Sep;3(6):518-24. doi: 10.2174/1389557033487908. Mini Rev Med Chem. 2003. PMID: 12871155 Review.
-
Structure-activity relationship of quaternary acetylcholinesterase inhibitors - outlook for early myasthenia gravis treatment.Curr Med Chem. 2010;17(17):1810-24. doi: 10.2174/092986710791111198. Curr Med Chem. 2010. PMID: 20345342 Review.
Cited by
-
Recent developments in the design and synthesis of benzylpyridinium salts: Mimicking donepezil hydrochloride in the treatment of Alzheimer's disease.Front Chem. 2022 Sep 26;10:936240. doi: 10.3389/fchem.2022.936240. eCollection 2022. Front Chem. 2022. PMID: 36226120 Free PMC article. Review.
-
Identification of AChE targeted therapeutic compounds for Alzheimer's disease: an in-silico study with DFT integration.Sci Rep. 2024 Dec 5;14(1):30356. doi: 10.1038/s41598-024-81285-2. Sci Rep. 2024. PMID: 39638823 Free PMC article.
-
Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase.RSC Adv. 2022 Jul 12;12(31):19764-19855. doi: 10.1039/d2ra03081k. eCollection 2022 Jul 6. RSC Adv. 2022. PMID: 35919585 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources